Catalyst Wire Dossier Catalyst Wire Dossier

Epcoritamab (Epcor)

epcoritamab · Genmab and AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epcoritamab (Epcor), covering 2024-07-22 to 2024-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL [Phase 2]

See pricing